Actively Recruiting
Cognitive Bias Modification for Interpretation (CBM-I) in People With Type 2 Diabetes and Persistent Pain
Led by University of Sydney · Updated on 2025-06-02
319
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to examine the efficacy of cognitive bias modification for interpretation (CBM-I) in people with Type 2 Diabetes and persistent pain. The main question\[s\] it aims to answer is whether interpretation bias training away from pain improves pain outcomes. Participants in the CBM-I group will complete 4 online training sessions approximately half an hour each. Each session will present participants with ambiguous scenarios which may be pain-related, however the final word of the sentence will resolve the scenario as benign (thus training participants to make benign interpretations). A measure of interpretation bias will be administered following the fourth training session, and pain severity and interference will be measured at baseline, post-training, two week follow up, and three month follow up. The study hypothesises that participants in the CBM-I group will demonstrate a greater reduction in the co-primary outcomes of pain severity and pain interference over time compared to those in the placebo control.
CONDITIONS
Official Title
Cognitive Bias Modification for Interpretation (CBM-I) in People With Type 2 Diabetes and Persistent Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age
- Have a diagnosis of Type 2 diabetes
- Have persistent pain present on more days than not for 3 months or longer
- Score 3 or higher on average pain severity on the Brief Pain Inventory
- Fluent in English
- Have access to internet and ability to use a computer over a three month period
You will not qualify if you...
- Under 18 years of age
- No diagnosis of Type 2 diabetes
- No persistent pain
- Not fluent in English
- No access to internet nor ability to use a computer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Sydney
Camperdown, New South Wales, Australia, 2006
Actively Recruiting
Research Team
T
Tessa Rooney
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here